Profiel
Mats-Olof Wallin is currently the Chief Financial Officer & Deputy CEO at OxThera AB since 2020.
Prior to this, he worked as the CFO & Director-Investor Relations at Biotage AB from 2003 to 2012, the Chief Financial Officer at Karo Healthcare AB from 2018 to 2019, and the Chief Financial Officer & Senior Vice President at Swedish Orphan Biovitrum AB from 2013 to 2018.
He completed his undergraduate degree from the University of Uppsala.
Actieve functies van Mats-Olof Wallin
| Bedrijven | Functie | Begin |
|---|---|---|
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Financieel Directeur/CFO | 01-01-2020 |
Eerdere bekende functies van Mats-Olof Wallin
| Bedrijven | Functie | Einde |
|---|---|---|
| KARO PHARMA AB (PUBL) | Financieel Directeur/CFO | 01-10-2019 |
| SWEDISH ORPHAN BIOVITRUM AB | Financieel Directeur/CFO | 20-07-2018 |
| BIOTAGE AB | Financieel Directeur/CFO | 01-01-2012 |
Opleiding van Mats-Olof Wallin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Karo Healthcare AB
Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Biotage AB
Biotage AB Medical SpecialtiesHealth Technology Develops workflow solutions, instruments and consumables used in drug discovery & pharmaceutical development | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
















